Mordovian heads of the SPIEF Pharmaceutical Industry.

The head of Mordovia, Artyom Zdunov, spoke about the development of the domestic pharmaceutical industry in the republic at the St. Petersburg International Economic Forum, the press service of the head of the region reports.

Participants of the Healthy Society session: a course for innovation and support of the Russian manufacturer" discussed the possibilities and plans for the implementation of innovative projects in the domestic pharmaceutical industry in modern realities.

"The head of Mordovia Artyom Zdunov was one of the main speakers at the session. He noted that pharmaceuticals is one of the priority areas for the republic and occupies an important place in the investment portfolio of the region. He stressed that the Biochemist plant of the Promomed Group of companies "It is not only a large international company, but also one of the most important taxpayers in the region," the message says. 

Speaking about the region's cooperation with the enterprise, Zdunov stressed the importance of working together to register new medicines and protect intellectual property. "In Mordovia, the main generator of intellectual activity results and then intellectual property objects is Biochemist, Promomed Group of companies. We are among the top innovative regions of the country, and pharmaceuticals play a significant role here," the press service quoted Zdunov as saying.

Yuri Zubov, Head of the Federal Service for Intellectual Property (Rospatent), noted that the chain of interaction between science, business, government and law enforcement is now well established in Mordovia. "The field of intellectual property is now in high demand and relevant, so it is necessary to deal with this. Besides, Saransk has become the capital of invention in Russia this year. Of Russia. Such a high title was won in a fair competition among many other regions," said the head of Rospatent, whose words are quoted in the message.

The head of Mordovia, speaking at the session, noted the importance of interaction with science and education. The Biochemist Plant, together with Ogarev Mordovian State University, is actively conducting research and development aimed at improving drug production technologies. The fight against the new coronavirus infection has demonstrated the high result of this cooperation.

We are talking about the clinical trials of the drug "Areplivir", developed by JSC "Biochemist". Two modern laboratories have been opened at the Ogarev Moscow State University Institute of Physics and Chemistry with the support of Promomed.

"Students come to work from universities and secondary vocational schools without any stress, because they already know production. We also attract specialists from other regions. In addition, we have a number of joint infrastructure projects with the company, and you will hear about them in the near future," said the head of Mordovia.

Dmitry Zemskov, Executive Director of Biochemist JSC, said that in Mordovia it was necessary to recreate a new production of antibiotics, revive chemical synthesis and synthesis of substances, and put new drugs into production.

"Original innovative drugs need patent protection at the state level. A pivotal event for the field of patent legislation took place in Mordovia – the Council on Intellectual property issues under the Chairman of the Federation Council. It allowed all participants in the process to reach mutual understanding in this area and gave impetus to the further development of this topic. As for support measures, our company confidently uses the opportunities provided by the Mordovian Industry Development Fund," the press service quoted Peter Bely, Chairman of the Board of Directors of Promomed Group.

Source: ria.ru

Sources

1. https://ria.ru/20220616/mordoviya-1795771900.html